Internal Medicine, Nephrology · Fort Worth, TX
NPI
1780658559
Since 2006
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
1902 Windsor Pl Ste 102
Fort Worth, TX, 76110
Phone (682) 207-1700
Groups this clinician bills Medicare through
Medicare paid, 2024
$183K
2,004 services
Medicare patients, 2024
501
Average age 72
Drug cost, 2024
$565K
1,195 prescriptions
Company payments, 2025
$1,200
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Koshy O Abraham was code 99232 (hospital e&m - subsequent), 549 times for 201 patients. In total Koshy O Abraham billed 2,004 services in 20 codes, and Medicare paid $183K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-10-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 549 | 201 | $60.03 | $33K |
| 99233 Hospital E&M - Subsequent | Facility | 475 | 198 | $91.58 | $44K |
| 99214 Office E&M - Established | Office | 212 | 97 | $74.22 | $16K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 193 | 68 | $12.87 | $2,484 |
| 99215 Office E&M - Established | Office | 152 | 18 | $137.62 | $21K |
| 99223 Hospital E&M - Initial | Facility | 103 | 95 | $135.18 | $14K |
| 90960 ESRD Related Services (not dialysis) | Office | 88 | 27 | $266.78 | $23K |
| 99232 Hospital E&M - Subsequent | Office | 38 | 20 | $61.29 | $2,329 |
| 99222 Hospital E&M - Initial | Facility | 37 | 36 | $97.18 | $3,596 |
| 99204 Office E&M - New | Office | 15 | 15 | $109.84 | $1,648 |
| 90961 ESRD Related Services (not dialysis) | Office | 15 | 12 | $227.81 | $3,417 |
| 99222 Hospital E&M - Initial | Office | 12 | 12 | $101.63 | $1,220 |
| 99223 Hospital E&M - Initial | Office | 12 | 12 | $124.21 | $1,491 |
By year: 2022 $191K for 1,799 services; 2023 $174K for 1,589 services; 2024 $183K for 2,004 services.
Medicare prescription drug claims, 2024
In 2024, the drug Koshy O Abraham prescribed most often to Medicare patients was Amlodipine Besylate, with 108 prescriptions and refills. In total Koshy O Abraham wrote 1,195 Medicare prescriptions that cost $565K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Amlodipine Besylate Generic | 108 | 262 | 32 | $847 |
| Farxiga Dapagliflozin Propanediol | 60 | 88 | 13 | $48K |
| Furosemide Generic | 60 | 142 | 24 | $348 |
| Carvedilol Generic | 59 | 131 | 20 | $260 |
| Pantoprazole Sodium Generic | 59 | 140 | 15 | $593 |
| Metoprolol Tartrate Generic | 55 | 96 | 11 | $486 |
| Losartan Potassium Generic | 40 | 88 | 12 | $282 |
| Sevelamer Carbonate Generic | 38 | 84 | 21 | $7,091 |
| Hydralazine Hcl Generic | 35 | 67 | 12 | $303 |
| Prednisone Generic | 33 | 81 | 12 | $207 |
| Tamsulosin Hcl Generic | 33 | 67 | Under 11 | $204 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 33 | 43 | 12 | $287 |
| Lisinopril Generic | 30 | 88 | 12 | $283 |
| Potassium Chloride Generic | 29 | 66 | Under 11 | $329 |
| Doxazosin Mesylate Generic | 27 | 61 | Under 11 | $603 |
Brand drugs: - claims; generic drugs: 985 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Koshy O Abraham $1,200 ($1,200 in general payments such as food, travel and fees) from 16 companies. The largest payer was Amgen Inc. with $306.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 14 | $306 |
| AstraZeneca Pharmaceuticals LP AZN | 11 | $220 |
| Calliditas Therapeutics US Inc. | 5 | $92.42 |
| Merck Sharp & Dohme LLC MRK | 5 | $88.95 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 4 | $83.7 |
| Bard Peripheral Vascular, Inc. BDX | 1 | $80.15 |
| Veloxis Pharmaceuticals, Inc. | 2 | $64.69 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 3 | $56.18 |
| Novo Nordisk Inc NVO | 2 | $49.85 |
| Scpharmaceuticals Inc. SCPH | 2 | $40.59 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.